Avantgen Inc.
San Diego, CA
- UEI
- WLNHKNPNT2M7
- CAGE
- 4NTY2
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 6162 Nancy Ridge Dr #150, San Diego, CA 92121, USA
- Website
- avantgen.com
- Founded
- 2006
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of rabbit monoclonal antibodies for ferret biomarkers. | National Institute of Allergy and Infectious Diseases | $1,497,384 | |
| A novel approach for treating myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) - abstract patients… | National Cancer Institute | $1,972,824 | |
| Definitive Contract 75N93024C00039 | National Institute of Allergy and Infectious Diseases | $592,751 | |
| Rapid acceleration of diagnostics (radx) program: tech project #7360 - highly sensitive rapid test kit for sars-COV-2… | National Heart Lung and Blood Institute | $3,750,864 | |
| Development of rapid and point-of-care diagnostic kit for hepatitis c virus detection | National Institute of Allergy and Infectious Diseases | $300,000 |
About Avantgen Inc.
Avantgen Inc. is a San Diego-based biotechnology company registered in the System for Award Management (SAM) since 2007, specializing in the development of advanced diagnostic technologies, monoclonal antibodies, and innovative therapeutic research. The company primarily serves federal agencies in the biomedical and infectious disease research sectors, with a focused expertise in developing rapid diagnostic test kits, therapeutic reagents, and specialized biomedical research tools. Through its federal contract and grant work, Avantgen demonstrates a strong capability in creating cutting-edge biotechnology solutions for complex medical and research challenges.
Avantgen has been awarded multiple federal contracts, predominantly from the National Institutes of Health (NIH) agencies, including the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Biomedical Imaging and Bioengineering. These contracts, which range from $300,000 to $3.75 million, have focused on developing rabbit monoclonal antibodies for various biomarkers, including ferret and bat virus research, and creating rapid diagnostic test kits for infectious diseases like SARS-CoV-2 and hepatitis C. Several contracts were set aside for small businesses, and the company has collaborated with subcontractors like Nanocomposix, Inc. and Duke University to expand its research capabilities and technical expertise.
The company has also received federal grant awards, most notably a $1,398,552 Project Grant from the National Cancer Institute to conduct preliminary IND-enabling studies for a novel antibody therapy targeting the Jagged-1 pathway in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). This research aims to develop innovative therapeutic approaches for blood cancers, focusing on creating an antibody that can disrupt critical oncogenic pathways in leukemic stem cells. The grant supports advanced preclinical research, including cell line development, early chemistry, manufacturing and controls (CMC) work, and preliminary toxicology studies on a lead antibody candidate designed to inhibit leukemic blast proliferation and induce apoptosis.
Quick answers
What is Avantgen Inc.'s UEI?
Avantgen Inc.'s Unique Entity ID (UEI) in SAM.gov is WLNHKNPNT2M7.
What is Avantgen Inc.'s CAGE code?
Avantgen Inc.'s CAGE code is 4NTY2.
What is Avantgen Inc.'s primary NAICS code?
Avantgen Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Avantgen Inc. located?
Avantgen Inc.'s physical address in SAM.gov is 6162 Nancy Ridge Dr #150, San Diego, CA 92121, USA.
Is Avantgen Inc. registered in SAM.gov?
Yes. Avantgen Inc.'s SAM.gov registration is active through November 5, 2026.
What is Avantgen Inc.'s most recent federal award?
Avantgen Inc.'s most recent federal contract award is Development of rabbit monoclonal antibodies for ferret biomarkers (75N93025C00013), from National Institute of Allergy and Infectious Diseases, on February 1, 2025.
On GovTribe
See Avantgen Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors